BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 21, 2016
View Archived Issues
VBI Vaccines develops novel Zika virus vaccine candidate
Read More
Synthorx completes Series B financing
Read More
Zafgen suspends development of beloranib and refocuses on ZGN-1061
Read More
Ionis Pharmaceuticals outlicenses oral antisense drug for GI autoimmune disease
Read More
Chronos Therapeutics acquires preclinical CNS programs
Read More
FDA approves expansion of Synjardy indication
Read More
Ono Pharmaceutical patents EP4 inhibitors
Read More
Bristol-Myers Squibb discloses Rho kinase inhibitors
Read More
Merck & Co. reports BTK inhibitors
Read More
Karos Pharmaceuticals presents tryptophan hydroxylase inhibitors
Read More
Teva Pharmaceutical Industries divulges antiviral compounds
Read More
Teva Pharmaceutical Industries reports compounds to treat cystic fibrosis
Read More
Cerecor awarded grant from NIAAA
Read More
FDA grants orphan drug designation to PEG-IL-10 for the treatment of pancreatic cancer
Read More
Chugai and Galderma sign license agreement for nemolizumab
Read More
EMA grants orphan drug designation to XOMA-358
Read More
Immuron and Australian research institutes partner to advance research in autism spectrum disorder
Read More
Aegerion to withdraw lomitapide in E.U.
Read More
Galenica to acquire Relypsa
Read More
Cell Medica's CMD-003 obtains European orphan drug designation
Read More
Amylyx Pharmaceuticals to receive funding for phase II study of AMX-0035 in ALS
Read More
Heterodimeric interleukin-15 can reduce viral reservoirs in SIV-infected macaques
Read More
Maruho and Galderma Pharma update progress made under strategic alliance
Read More
PeptiDream licenses peptide discovery platform to Genentech
Read More
AbCellera Biologics discloses new antibody collaboration with MassBiologics
Read More
Nascent Biotech licenses rights for pritumumab to Hisun in China
Read More
Overactive mGlu5 receptor signaling shows promise as a tractable mechanism-based target for OCD
Read More
Epclusa efficacy unaffected by negative predictors of virological response
Read More